Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-13
2006-06-13
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S268100, C546S348000
Reexamination Certificate
active
07060716
ABSTRACT:
Compounds of the formula (I), in which M is a central building block selected from the group below in which A1, A2, K1 and K2 are as defined in the description, are novel effective tryptase inhibitors.
REFERENCES:
patent: 6489327 (2002-12-01), Bär et al.
patent: WO 95/32945 (1995-12-01), None
patent: WO 96/09297 (1996-03-01), None
patent: WO 98/04537 (1998-02-01), None
patent: WO 99/12918 (1999-03-01), None
patent: WO 99/24395 (1999-05-01), None
patent: WO 99/24407 (1999-05-01), None
patent: WO 99/40073 (1999-08-01), None
patent: WO 99/40083 (1999-08-01), None
patent: WO 00/14097 (2000-03-01), None
patent: WO 01/10845 (2001-02-01), None
patent: WO 01/10848 (2001-02-01), None
patent: WO 01/19809 (2001-03-01), None
patent: WO 01/46128 (2001-06-01), None
patent: WO 01/46168 (2001-06-01), None
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Vippagunta et al., Advanced Drug Delivery Reviews 48: 3-26, 2001.
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
See Oh et al., Journal of Immunology, 1992-2000, 2002.
Sommerhoff, American Journal of Respiratory and Critical Care Medicine , 164: 552-558. 2001.
Krishna, et al., “Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma”,J. Allergy Clin. Immunol., Jun., 2001, pp. 1039-1045.
Rice, et al., “Dibasic Inhibitors of human mast cell tryptase. Part 2: Structure-Activity Relationships and Requirements for Potent Activity”, Bioorganic & Medicinal Chemistry Letters 10, pp. 2361-2366 (2000).
Altana Pharma AG
Balasubramanian Venkataraman
Goldberg Joshua B.
McGee Sheldon M.
Nath & Associates
LandOfFree
Tryptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tryptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tryptase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3689152